TY - JOUR
T1 - Adrenocortical tumours in children and adults
T2 - A study of pathological and proliferation features
AU - Sredni, Simone Treiger
AU - Ferreira Alves, Venâncio Avancini
AU - Rosário Latorre, Maria Do
AU - Nogueira Zerbini, Maria Claudia
N1 - Funding Information:
ACKNOWLEDGEMENTS The authors thank Adhemar L. Filho, Department of Pathology, Adolpho Lutz Institute, Sao Paulo, Brazil, for permission to use the Image Analyzer Laboratory facilities; Ney S. Araujo and Vera C. Araujo, Department of Pathology, University of Sao Paulo's Dentistry School, for permission to use the Research Laboratory of Pathology; Cristina A. Martins and S6nia S. L. Silva for technical support; and Jacques Sredni for English review. This study was supported by FAPESP (Grant 96/2272-0), and FMUSP Foundation.
PY - 2003/4
Y1 - 2003/4
N2 - Aims: To demonstrate the correlation between morphological and proliferation parameters with the biological behaviour of adrenocortical tumours (ACTs) in different age groups. Methods: Seventy-six cases of ACT were evaluated comparing tumours of children (≤15 years, n=24) and adults (≥15 years, n=52) regarding morphological features and proliferation rates. These parameters were also compared in clinically benign (CB) and clinically malignant (CM) tumours. Tumours were analysed according to Weiss' histological parameters. Proliferation rates were assessed by MIB-1 labelling index and silver binding nucleolar organiser regions (AgNORs) were quantified by image analysis. Results: ACTs in children presented higher proliferative activity than in adults. In adult's ACTs, MIB-1 labelling index (cut-off, 10%) (P=0.037) and the AgNOR pattern (P<0.001) had influence over the disease-free survival (DFS). The AgNOR pattern type I was associated with CB-ACT and the AgNOR pattern type II with CM-ACT. The AgNOR pattern type III was characteristic of children's ACTs and type IV was characteristic of non-neoplasic adrenal glands. Conclusion: ACTs in children had a different morphological spectrum and higher proliferative activity than those tumours in adults, which should be always analysed as a separate group. In adults, our findings reinforce that the morphological criteria proposed by Weiss are an efficient way of differentiating CB-ACT from CM-ACT.
AB - Aims: To demonstrate the correlation between morphological and proliferation parameters with the biological behaviour of adrenocortical tumours (ACTs) in different age groups. Methods: Seventy-six cases of ACT were evaluated comparing tumours of children (≤15 years, n=24) and adults (≥15 years, n=52) regarding morphological features and proliferation rates. These parameters were also compared in clinically benign (CB) and clinically malignant (CM) tumours. Tumours were analysed according to Weiss' histological parameters. Proliferation rates were assessed by MIB-1 labelling index and silver binding nucleolar organiser regions (AgNORs) were quantified by image analysis. Results: ACTs in children presented higher proliferative activity than in adults. In adult's ACTs, MIB-1 labelling index (cut-off, 10%) (P=0.037) and the AgNOR pattern (P<0.001) had influence over the disease-free survival (DFS). The AgNOR pattern type I was associated with CB-ACT and the AgNOR pattern type II with CM-ACT. The AgNOR pattern type III was characteristic of children's ACTs and type IV was characteristic of non-neoplasic adrenal glands. Conclusion: ACTs in children had a different morphological spectrum and higher proliferative activity than those tumours in adults, which should be always analysed as a separate group. In adults, our findings reinforce that the morphological criteria proposed by Weiss are an efficient way of differentiating CB-ACT from CM-ACT.
KW - Adrenocortical tumours
KW - AgNOR
KW - Image analysis
KW - MIB-1
KW - Pathology
KW - Prognosis
KW - Proliferation
UR - http://www.scopus.com/inward/record.url?scp=0038289067&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0038289067&partnerID=8YFLogxK
U2 - 10.1080/00313020307569
DO - 10.1080/00313020307569
M3 - Article
C2 - 12745460
AN - SCOPUS:0038289067
SN - 0031-3025
VL - 35
SP - 130
EP - 135
JO - Pathology
JF - Pathology
IS - 2
ER -